Cargando…
Successful induction treatment of bullous pemphigoid using reslizumab: a case report
BACKGROUND: Bullous pemphigoid (BP) is a potentially life-threatening autoimmune blistering disease which is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. In recent years, the role of eosinophil and immunoglobulin E autoantibodies have been further...
Autores principales: | Rhyou, Hyo-In, Han, Song-Hee, Nam, Young-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596938/ https://www.ncbi.nlm.nih.gov/pubmed/34784964 http://dx.doi.org/10.1186/s13223-021-00619-1 |
Ejemplares similares
-
Refractory Bullous Pemphigoid Successfully Treated with Reslizumab: A Possible Novel Therapeutic Modality
por: Kwon, Hyeok-Jin, et al.
Publicado: (2023) -
Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab
por: Nam, Young-Hee
Publicado: (2023) -
Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report
por: Liu, Jing-Hua, et al.
Publicado: (2023) -
Successful treatment of refractory eosinophilic fasciitis with reslizumab
por: Mortezavi, Mahta, et al.
Publicado: (2020) -
Tozinameran: Bullous pemphigoid: case report
Publicado: (2022)